VR Exposure Therapy for Dog Phobia: Clinical Protocol

Dog Phobia: What the DSM-5-TR Says

Dog phobia is diagnosed as Specific Phobia, 'Animal' subtype (DSM-5-TR, code F40.218). Summarized criteria: intense fear or anxiety triggered by the presence or anticipation of dogs, almost always provoked immediately; active avoidance or endurance with significant distress; fear disproportionate to the actual danger posed; duration ≥6 months; clinically significant distress or impairment in functioning.

Mandatory differential diagnosis: PTSD (if a clearly identified traumatic event is present, PTSD takes precedence), OCD with animal-avoidance compulsions (in which case treatment changes), and GAD with generalization to multiple phobias (in which case treating the primary GAD is preferable).

Frequent comorbidity: mild depression secondary to activity restriction, generalized anxiety, other specific phobias (claustrophobia, heights). In Spanish private practice, roughly 40% of patients with dog phobia present at least one other active specific phobia.

When to Use VR and When to Use In Vivo

The gold standard for exposure is in vivo. VR does not replace it: it complements or precedes it.

VR is indicated when: (1) the patient declines in vivo exposure at initial assessment, (2) fine-grained control of variables (dog size/breed, distance, activity, barking) is clinically relevant, (3) in vivo logistics are prohibitive (comorbid allergy, housing without access to a controllable dog, cities without cooperating dog shelters), (4) the patient needs to repeat a level far more times than is logistically feasible in vivo.

In vivo is indicated when: (1) the patient accepts and tolerates contact with a real dog from the initial phase, (2) generalization to the natural environment is the priority goal, (3) a close family member has a pet dog that offers a realistic context, (4) treatment closure requires ecological proof.

Practical recommendation: start with VR for the first 4-6 levels if the patient would not tolerate in vivo exposure from the outset, then transition to in vivo for the last 1-2 levels to ensure generalization. The transition should be explicit and planned, not left to chance.

VR Exposure Hierarchy for Dog Phobia: 5 Levels

Level 1 — small, still dog, 3 m distance, neutral setting. Session length: 5-7 min. Target SUDS ≤4 by the end. Repeat until ≤4 is achieved in two consecutive sessions before advancing.

Level 2 — small dog in motion, 2 m distance, distant barking audio. Session length: 7-10 min. Gradual audio introduction: start with the dog silent, add distant barking at 3 min, a brief close bark at 6 min.

Level 3 — medium-sized dog off-leash in a room, variable distance 1-3 m. Session length: 10-15 min. Many patients briefly return to level 2 here; this is normal and clinically productive.

Level 4 — large dog in a park, multiple urban stimuli. Session length: 15-20 min. Introduce variability: 2-3 dogs simultaneously, passersby, multiple barks.

Level 5 — urban walk scene with unpredictable encounters. Session length: 20-25 min. Goal: the patient can complete the scenario without requesting a pause, SUDS ≤3 at close. The dog phobia clinical catalog has the full DSM-5-TR detail, specific contraindications, and the technical page for the VRET scenario (Dog Phobia).

In vivo transition: 1-2 planned sessions with a controllable real dog (family pet, cooperating dog handler) after Level 5 is passed. Without this transition, generalization remains incomplete.

Contraindications You Will Encounter

Absolute: diagnosed photosensitive epilepsy, active peripheral vertigo, first-trimester pregnancy with vertiginous episodes, migraine with severe aura.

Relative (require case-by-case evaluation): dissociative disorders, active psychosis, somatic inner-ear comorbidity, pediatric patients < 8 years old due to headset ergonomics, progressive lenses (resolvable with a Quest 3 optical insert).

Cybersickness specifically in dog phobia: incidence is low (~10%) because most VR dog phobia scenarios are stationary (the patient sits or stands in a fixed spot while the dog moves). If nausea emerges, mitigate with shorter sessions (5-7 min initially) and pauses every 5 min.

SUDS Template and Post-Session Debriefing

Baseline pre-session SUDS: record 0-100 before putting on the headset. If baseline SUDS > 60, consider postponing the session.

In-session SUDS: record at 0, 5, 10, 15, 20 min, and at close. If SUDS > 80 is sustained for 3 min, remove the headset and move directly to debriefing.

Post-session SUDS: record at 5 min after removing the headset and again at 24h via a follow-up message.

Post-session debriefing: 10 min minimum. Key questions: What was hardest about today's level? What changed when the barking pushed SUDS to 70? Which level do you want to repeat, and which do you want to advance to? Close with a between-session task (passive observation of dogs from a distance, reading specific literature, etc.).

When Treatment Ends

Discharge criteria: (1) Level 5 passed with SUDS ≤3 at close, (2) at least 1-2 in vivo sessions completed successfully, (3) reactivity to unplanned chance encounters reported by the patient as 'manageable' on their own subjective scale, (4) absence of active avoidance in the patient's daily routine.

This article is for informational purposes for psychology professionals. It is not clinical advice for any individual case and does not replace the judgment of the licensed psychologist in charge. VRET is professional clinical-support software, not a CE-marked medical device.